https://www.selleckchem.com/pr....oducts/upadacitinib.
Quality of life can be influenced by oral mucositis (OM), and it is necessary to implement OM management strategies before the initiation of radiotherapy (RT) in patients with head and neck cancer (HNC). To examine the association between the cumulative radiation dose and the incidence of severe OM in HNC patients receiving RT. A retrospective observational cohort study was conducted in a Showa University Fujigaoka Hospital, in Japan. We retrospectively analyzed 94 patients with HNC who developed OM during RT. We defined OM as a mo
Me gusta
Comentario
Compartir
